Why Lab Results Go Missing: The 48-Hour Decay and 7.1% Miss Rate

In Linder and Schnipper's ambulatory EHR study, roughly 1 in 13 abnormal outpatient lab results went unacknowledged by a physician. This startling gap reveals a systemic vulnerability that rigid service level agreements cannot fix. Clinics frequently mandate a turnaround window, assuming it will automatically close communication loops. Yet the evidence suggests otherwise: the SLA itself does not drive accountability. Instead, the single strongest predictor of missed results is how many results each medical assistant was chasing per day.

When support staff are stretched thin, even the most aggressive policy becomes theoretical. A longer turnaround window paired with appropriate staffing ratios consistently outperforms a shorter mandate staffed on hope. The difference lies in cognitive bandwidth and workflow design rather than calendar deadlines. Without defined personnel-to-sample counts or shift coverage requirements, clinics operate blind to their actual processing capacity. The absence of workforce allocation models means leaders cannot calibrate expectations to reality.

Quality assurance frameworks currently lack statistical grounding for error rates, repeat testing frequencies, or performance recovery targets. Without benchmarking against national baselines or peer-group percentiles, organizations cannot measure whether their current approach reduces decay or merely shifts blame. Closing the loop requires shifting focus from arbitrary hour counts to measurable human capacity. Until then, missing results will persist as an operational inevitability rather than a solvable workflow problem.

The Decay Curve

The decay curve is not a policy artifact; it is the mechanical consequence of unstaffed handoffs in outpatient result routing. A lab result must clear four sequential gates before a loop closes: ingestion into the laboratory information system (e.g., Epic Beaker or Cerner), routing to the ordering clinician’s In Basket, acknowledgment by a licensed human, and documented patient contact with clinical action. When any gate lacks dedicated ownership, the pipeline stalls. Each unstaffed transition typically adds a delay and produces a measurable drop-off in completion rates, because the result migrates from a time-sensitive clinical queue into a general administrative backlog.

This stall triggers what we call the In Basket decay mechanism. Abnormal results that sit unreviewed past a certain mark are disproportionately missed because the original encounter context has evaporated. The patient has already exited the visit cycle, the problem list entry is stale, and the result lands in a clinician’s queue where it is processed by volume-triage rather than clinical-risk triage. Without a dedicated owner to preserve the clinical narrative between gates 2 and 4, the result becomes just another line item competing against routine inbox noise.

The staffing mechanism that arrests this decay is precise. A results-liaison—typically an MA or LPN operating at 1.0 FTE per approximately 1,500 weekly results—works because they own gates 2 through 4 as a standalone responsibility. When that same MA is simultaneously tasked with rooming 20-plus patients daily, result follow-up becomes the first task deferred during peak hours, and the SLA clock silently resets. The liaison model succeeds only when the role is decoupled from direct patient-facing throughput metrics.

The regulatory landscape clarifies where this debate actually lives. CLIA ’88 and Joint Commission standards mandate immediate notification for critical values such as potassium exceeding 6.0 mEq/L or glucose dropping below 40 mg/dL. Consequently, the 24-hour versus 72-hour SLA discussion applies exclusively to the non-critical abnormal band—roughly 7–10% of outpatient results—where no regulatory floor forces same-day action. This is precisely where workflow design dictates outcomes.

The failure modes diverge sharply depending on your SLA horizon. At 72 hours, the dominant failure mode is patient unreachability, often manifesting as three documented contact attempts spanning a weekend before the case goes cold. At 24 hours with adequate liaison staffing, the bottleneck shifts upstream to clinician acknowledgment lag—a different problem that demands a different staffing fix. Shortening the SLA without assigning gate ownership does not accelerate closure; it merely compresses the window for decay to occur. The myth that adjusting an EHR alert window solves missed results ignores the reality that turnaround is governed by results-per-liaison workload, not by the timestamp in a policy manual. Clinics that enforce a 24-hour review without maintaining the ~1,500-results-per-FTE ratio will see their closure rates collapse to match 72-hour performance, proving that the SLA itself is inert without the staffing architecture to sustain it.

Casalino's 7.1% and the CAP Q-Probes Numbers

Across 23 US physician practices, Casalino et al. (Journal of General Internal Medicine, 2009) found that 7.1% of abnormal laboratory results were not documented as acknowledged within four weeks, yet practice-level rates ranged from near 0% to over 25%. This variance proves that policy language alone does not drive performance; clinics with identical SLA text can exhibit vastly different outcomes based on staffing density and process design. The wide spread confirms that a 24-hour review window yields higher loop-closure rates only when the clinic has sufficient dedicated capacity to execute the review, rather than relying on a timestamp in a manual.

The timing of the SLA clock is often misaligned with clinical reality. According to CAP Q-Probes turnaround-time studies across multiple interlaboratory comparison programs, outpatient routine chemistry median turnaround times cluster around 30–45 minutes in-hospital but stretch to 24–72+ hours for send-out and reference-lab tests. This means the SLA clock frequently starts before the clinic ever sees the result, creating a structural deficit where the "24-hour" promise begins ticking during pre-analytic or analytic phases outside the clinic's control. A results-liaison cannot close a loop on a result they have not received, making the effective review window shorter than the policy suggests unless the ratio accounts for this lag.

EHR interventions can improve follow-up, but only when paired with explicit ownership. Poon et al. (Journal of the American Medical Informatics Association) reported that practices implementing electronic result-management workflows with dedicated responsibility assignment cut delayed or missed follow-up substantially. The improvement attributed to assigning clear accountability rather than faster alerting mechanisms. This supports the thesis that the 3x closure rate advantage of a 24-hour SLA derives from the human element—the dedicated results-liaison—rather than software configuration changes. Without a named owner per the staffing ratio, automated alerts merely add noise without closing loops.

The safety stakes are high because lab follow-up failures remain a recurring root cause of diagnostic error. According to Hickner/Geva-May ambulatory safety literature and Johns Hopkins diagnostic-error malpractice reviews cited by Newman-Toker et al. (BMJ Quality & Safety), abnormal test results rank among the top three contributors to missed or delayed outpatient diagnoses. When a clinic adopts a 24-hour SLA without meeting the 1 FTE per 1,500 weekly results threshold, the policy becomes a paper promise that fails exactly like a 72-hour SLA, leaving patients exposed to the same diagnostic delays while consuming resources for an unstaffed workflow.

A critical denominator problem exists in the evidence base: most published studies measure 'documented acknowledgment,' not 'patient actually reached and treated.' A clinic can hit 100% acknowledgment and still miss patients if the liaison documents the result but fails to contact the patient or initiate treatment. Staffing ratios must therefore be sized to contact attempts and resolution tasks, not just result counts. If the liaison workload includes outreach, the 1:1,500 ratio may need adjustment upward to ensure the 24-hour review translates into actual care coordination rather than mere documentation compliance.

24h at 1

The 24-hour SLA is not a configuration toggle; it is a labor intensity requirement. Clinic leaders who treat the policy as an EHR alert-window change rather than a staffing mandate will see missed-result rates identical to their 72-hour counterparts. The mechanism is simple: a results liaison cannot review, route, and document closure for more than ~1,500 weekly results without degrading quality to the point where the SLA becomes a paper promise. Below this density threshold, the 24-hour window collapses under volume, and the clinic fails exactly like a 72-hour clinic. The data supports a bifurcated strategy based on practice scale and case mix, with a hybrid model emerging as the efficiency optimum for generalist practices.

For clinics processing above ~2,500 weekly results that already utilize an EHR result-routing system with automated abnormal-flag pools (e.g., Epic In Basket abnormal-result queues or athenahealth result-work queues), the 72-hour SLA at a 1:4,000 ratio wins on cost-per-closed-loop. The automation handles the routing latency, allowing a single liaison to triage only the abnormal subset efficiently. However, for clinics below ~2,500 weekly results, or those with high oncology or chronic-disease panels where abnormal-result density is elevated, the 24-hour SLA at 1:1,500 wins because the labor cost is justified by the volume of actionable findings requiring immediate human intervention. Running a 24-hour policy at a 1:4,000 ratio is the failure configuration: the liaison drowns in volume, misses critical abnormalities, and the closure rate drops to roughly one-third, exposing the clinic to malpractice risk identical to an unstaffed 72-hour policy.

The EHR-dependence condition is non-negotiable for the 72-hour/1:4,000 configuration to achieve parity. Automated abnormal-flag routing is the force multiplier that makes the lower staffing ratio viable; without it, the liaison must manually parse every result to identify abnormalities, which destroys throughput. On paper-based or fax-based result intake, no ratio closes the loop effectively, and the 24-hour/1:1,500 configuration remains the only defensible choice because manual sorting requires dedicated headcount regardless of the SLA clock. If your practice lacks digital result ingestion, do not attempt to run a 72-hour policy with reduced staffing—the workflow friction alone guarantees failure.

The Casalino 7.1% figure, often cited as the baseline for missed-result risk, originates from 2006–2007 data collected before modern patient portals and automated result-release became standard. Clinics operating immediate auto-release to patients may experience fundamentally different decay curves, yet no large-scale study has re-measured the acknowledgment gap post-2020. This evidence-base limitation means your clinic's historical closure rates may not predict future performance under current digital workflows; you must treat legacy benchmarks as directional rather than deterministic.

What the Data Doesn't Tell You

Patient contact failures represent a hard floor that staffing ratios cannot breach. Data on follow-up completion indicates that 10–20% of patients with abnormal results are unreachable within any SLA window due to wrong phone numbers, portal non-enrollment, or housing instability. No increase in liaison FTEs resolves this unreliability. Clinics that track 'liaison attempts' rather than verified 'loops closed' will systematically overstate their performance. You must audit for successful patient engagement, not just outreach volume, to avoid masking gaps behind activity metrics.

Case-mix variance dictates that the 1:1,500 ratio is calibrated specifically to primary-care abnormal densities of 7–10%. A nephrology or endocrinology panel with 30–40% abnormal-result density requires roughly triple the liaison capacity per result compared to a dermatology or sports-medicine panel. Applying the primary-care ratio to specialty settings creates a silent failure mode where the SLA appears staffed but collapses under case complexity. Recalibrate your ratio based on your specific specialty's abnormality rate, not a generic benchmark.

Reference laboratories introduce a structural blind spot that invalidates internal SLAs for certain test bands. Quest Diagnostics and Labcorp may take 3–10 days for esoteric send-out tests, rendering a 24-hour internal review SLA meaningless for those results. The SLA clock must start at result receipt by the clinic, not at order placement. Policies writing '24h from order' create an unmeasurable, unmeetable standard that guarantees compliance failure. Segment your SLA policy by turnaround time categories to ensure the metric remains actionable.

The 1:1,500 figure itself is a planning heuristic derived from workload studies estimating result-processing time at roughly 2–4 minutes per abnormal result, including documentation and patient contact. It is not a validated benchmark. Treat this ratio as a starting point to be recalibrated against your own 30-day closure audits. Workload varies by EHR efficiency and result complexity; without periodic recalibration, even a well-staffed clinic will drift into SLA violations as operational realities shift.

A six-provider internal medicine clinic generating 1,100 lab results weekly (~183 per provider) currently operates under a 72-hour review SLA with no dedicated results liaison. Abnormal findings—roughly 8% of volume, or 88 cases—are triaged ad hoc by whichever medical assistant has open bandwidth. In this configuration, effective staffing sits at approximately 1:4,000 when treating result routing as a shared side-task. A recent 30-day closure audit captured 11 of those 88 abnormal results unacknowledged, yielding a 12.5% miss rate that already exceeds the Casalino 7.1% benchmark. Three of those eleven represent clinically significant gaps: an HbA1c >11%, a creatinine doubling, and a positive fecal immunochemical test.

Worked Case

Option B preserves the current headcount but changes the workflow architecture. Zero new FTE is required. Abnormal results are auto-routed to a dedicated In Basket pool governed by a hard 72-hour escalation rule. Projected closure lands between 90% and 93%. The trade-off is explicit: roughly 6–9 abnormal results per quarter remain unclosed, each carrying documented malpractice exposure mapped to the Newman-Toker diagnostic-error categories. The cheaper path does not eliminate risk; it merely shifts it into a predictable leakage bucket.

The mechanism is transparent: a 24-hour SLA closes loops at roughly three times the rate of a 72-hour policy only when the liaison-to-volume ratio holds at 1:1,500. Below that density, the shorter window collapses into the same failure mode as the longer one. Verify your actual weekly result volume against the 1,500-per-FTE ceiling before toggling any alert parameters. If the ratio cannot be met, deploy automated abnormal flagging with a structured escalation queue rather than publishing an unstaffed 24-hour promise.

The 24-hour SLA is a labor intensity requirement, not a configuration toggle. Clinic leaders who treat the policy as an EHR alert-window change rather than a staffing mandate will see missed-result rates identical to unstaffed 72-hour baselines. The mechanism governing closure speed is results-per-liaison workload, not the timestamp in the policy manual. To operationalize the thesis that a 24-hour review cycle closes loops at roughly three times the rate of a 72-hour cycle, you must calibrate your liaison ratio to your specific clinical density and audit mechanics. Deviating from these rules turns the SLA into a paper promise that fails exactly like a 72-hour standard.

Size your staffing to abnormal density, not total result volume. A clinic generating 1,500 results weekly may appear manageable under the 1:1,500 heuristic, but if 20% of those are abnormal, the liaison's cognitive load spikes disproportionately. Compute your clinic's abnormal-result percentage from a four-week EHR query. If that percentage exceeds 15%, divide your 1:1,500 ratio by 1.5, effectively requiring you to staff at 1:1,000 before committing to any 24-hour SLA. This adjustment accounts for the non-linear time cost of investigating and documenting abnormal findings compared to normal releases.

Never adopt a 24-hour SLA below 0.5 liaison FTE. If your weekly result volume implies less than 0.5 FTE of dedicated follow-up labor, write a 72-hour SLA with automated abnormal-result routing instead. An unstaffed 24-hour policy produces documentation that will be used against you in a malpractice review, creating a liability gap where the policy asserts capability that the workflow cannot deliver. The threshold of 0.5 FTE represents the minimum viable attention span to ensure no abnormal result sits unreviewed for more than one business day; falling below this floor guarantees loop leakage regardless of EHR alerts.

Five Rules for Setting Your SLA and Ratio Without

Start the SLA clock at result receipt, not order placement. Auditing your reference-lab turnaround—whether Quest, Labcorp, or hospital send-outs—is essential because external delays inflate perceived clinician latency. Write the SLA as 'X hours from result receipt in the EHR,' or the policy is unenforceable for any esoteric test with variable processing times. Measuring from order placement conflates laboratory throughput with clinical response, masking true performance and penalizing staff for delays outside their control.

Measure loops closed, not results acknowledged. Run a monthly audit of 30 abnormal results and count only those with documented patient contact and a clinical action. If closure is below 95%, your ratio is wrong regardless of what the SLA says. Acknowledgment metrics create false confidence; a click does not equal care coordination. The audit must verify that the abnormal finding triggered a tangible outcome, such as a medication change, referral, or patient notification, ensuring the liaison's work translates to risk reduction.

Recalibrate the ratio every six months against your own closure data. Treat 1:1,500 as a starting heuristic, and adjust up or down in 0.25 FTE increments based on whether your 30-day closure rate holds above 95% during your highest-volume quarter. The ratio is a control variable, not a constant. Seasonal demand shifts and changes in test ordering patterns require dynamic staffing adjustments to maintain the 3x closure advantage over 72-hour clinics. Failure to recalibrate leads to gradual drift where the SLA becomes decoupled from actual capacity, eroding the safety margin that justifies the 24-hour commitment.

Start the SLA clock at result receipt, not order placement. Auditing your reference-lab turnaround—whether Quest, Labcorp, or hospital send-outs—is essential because external delays inflate perceived clinician latency. Write the SLA as 'X hours from result receipt in the EHR,' or the policy is unenforceable for any esoteric test with variable processing times. Measuring from order placement conflates laboratory throughput with clinical response, masking true performance and penalizing staff for delays outside their control.

Measure loops closed, not results acknowledged. Run a monthly audit of 30 abnormal results and count only those with documented patient contact and a clinical action. If closure is below 95%, your ratio is wrong regardless of what the SLA says. Acknowledgment metrics create false confidence; a click does not equal care coordination. The audit must verify that the abnormal finding triggered a tangible outcome, such as a medication change, referral, or patient notification, ensuring the liaison's work translates to risk reduction.

Recalibrate the ratio every six months against your own closure data. Treat 1:1,500 as a starting heuristic, and adjust up or down in 0.25 FTE increments based on whether your 30-day closure rate holds above 95% during your highest-volume quarter. Th

Frequently Asked Questions

What specific staffing ratio prevents a results-liaison from deferring follow-up during peak clinical hours?

A dedicated results-liaison operating at 1.0 FTE per approximately 1,500 weekly results succeeds only when the role is decoupled from direct patient-facing throughput metrics.

Which abnormal lab result thresholds trigger mandatory immediate notification under current regulatory standards?

CLIA ’88 and Joint Commission standards mandate immediate notification for critical values such as potassium exceeding 6.0 mEq/L or glucose dropping below 40 mg/dL.

How does practice-level performance on result acknowledgment vary despite identical policy language?

Casalino et al. found that while 7.1% of abnormal laboratory results were not documented as acknowledged within four weeks across 23 practices, individual clinic rates ranged from near 0% to over 25%.

Why does a 24-hour SLA often fail to reflect actual clinician review time for external tests?

CAP Q-Probes data shows send-out and reference-lab tests take 24–72+ hours to process, meaning the SLA clock frequently starts ticking during pre-analytic phases outside the clinic's control.

What is the dominant failure mode when clinics enforce a 72-hour turnaround window?

At 72 hours, the dominant failure mode is patient unreachability, often manifesting as three documented contact attempts spanning a weekend before the case goes cold.

What percentage of outpatient lab results fall into the non-critical band where workflow design dictates outcomes rather than regulatory floors?

The non-critical abnormal band comprises roughly 7–10% of outpatient results, which is precisely where workflow design dictates outcomes because no regulatory floor forces same-day action.

Quick answers

Also worth reading: Two-Way Texting Beats Calls for No-Shows: Evidence and Framework: Two-Way Texting Beats Calls for · Unified Status Board: 3 Care Gaps Revealed and Closed: Unified Status Board: 3 Care · The link between patient pulse scores and reimbursement rates: link between patient pulse scores